Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
35.00
-0.12 (-0.34%)
At close: Jun 16, 2026, 4:00 PM EDT
35.10
+0.10 (0.29%)
Pre-market: Jun 17, 2026, 5:16 AM EDT
Crinetics Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Crinetics Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $83.14. The average 1-year stock price forecast is 137.54% higher than the current stock price, while the lowest is $55 (+57.14%) and the highest is $97 (+177.14%).
Price Target: $83.14 (+137.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Crinetics Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $95 | Buy | Maintains | $95 | +171.43% | Jun 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Reiterates $89 → $88 | Buy | Reiterates | $89 → $88 | +151.43% | May 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $87 → $84 | Buy | Maintains | $87 → $84 | +140.00% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $97 | Buy | Maintains | $97 | +177.14% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $83 | Buy | Maintains | $83 | +137.14% | May 8, 2026 |
Financial Forecast
Revenue This Year
68.55M
from 7.70M
Increased by 790.73%
Revenue Next Year
173.02M
from 68.55M
Increased by 152.40%
EPS This Year
-4.78
from -4.95
EPS Next Year
-4.21
from -4.78
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 76.1M | ||
| Avg | 68.6M | ||
| Low | 57.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 888.6% | ||
| Avg | 790.7% | ||
| Low | 650.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.87 | ||
| Avg | -4.78 | ||
| Low | -5.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |